🇺🇸 FDA
Patent

US 10201543

Therapeutically active compounds and their methods of use

granted A61KA61K31/53A61P

Quick answer

US patent 10201543 (Therapeutically active compounds and their methods of use) held by Agios Pharmaceuticals, Inc. expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Agios Pharmaceuticals, Inc.
Grant date
Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/53, A61P, A61P35/00, A61P35/02